| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $12.39B | $9.65B | $7.96B |
| YoY Revenue Growth % | +28.5% | +21.2% | — |
| Gross Profit | $1.49B | $1.03B | — |
| Gross Margin % | 12.1% | 10.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.04B | $599.3M | $338.3M |
| Operating Margin % | 8.4% | 6.2% | 4.2% |
| Net Income (GAAP) | $832.5M | $428.0M | $244.4M |
| EBITDA (Normalized) | $1.49B | $946.6M | $624.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $659.5M | $473.9M | $326.2M |
| Capital Expenditures (CapEx) | $557.6M | $434.1M | $358.2M |
| Free Cash Flow (FCF) | $101.9M | $39.8M | -$32.0M |
| FCF Margin % | 0.8% | 0.4% | -0.4% |
| Return on Invested Capital (ROIC %) | 21.2% | 14.3% | 2.3% |
| Cash & Short-Term Equivalents | $595.6M | $423.3M | — |
| Total Debt (Short + Long Term) | $2.25B | $1.84B | $4.59B |
| Total Stockholders' Equity | $2.22B | $1.90B | $9.41B |